312 related articles for article (PubMed ID: 12877578)
1. Selective protein tyrosine phosphatase 1B inhibitors: targeting the second phosphotyrosine binding site with non-carboxylic acid-containing ligands.
Liu G; Xin Z; Liang H; Abad-Zapatero C; Hajduk PJ; Janowick DA; Szczepankiewicz BG; Pei Z; Hutchins CW; Ballaron SJ; Stashko MA; Lubben TH; Berg CE; Rondinone CM; Trevillyan JM; Jirousek MR
J Med Chem; 2003 Jul; 46(16):3437-40. PubMed ID: 12877578
[TBL] [Abstract][Full Text] [Related]
2. Discovery and structure-activity relationship of oxalylarylaminobenzoic acids as inhibitors of protein tyrosine phosphatase 1B.
Liu G; Szczepankiewicz BG; Pei Z; Janowick DA; Xin Z; Hajduk PJ; Abad-Zapatero C; Liang H; Hutchins CW; Fesik SW; Ballaron SJ; Stashko MA; Lubben T; Mika AK; Zinker BA; Trevillyan JM; Jirousek MR
J Med Chem; 2003 May; 46(11):2093-103. PubMed ID: 12747781
[TBL] [Abstract][Full Text] [Related]
3. Fragment screening and assembly: a highly efficient approach to a selective and cell active protein tyrosine phosphatase 1B inhibitor.
Liu G; Xin Z; Pei Z; Hajduk PJ; Abad-Zapatero C; Hutchins CW; Zhao H; Lubben TH; Ballaron SJ; Haasch DL; Kaszubska W; Rondinone CM; Trevillyan JM; Jirousek MR
J Med Chem; 2003 Sep; 46(20):4232-5. PubMed ID: 13678400
[TBL] [Abstract][Full Text] [Related]
4. Structure-based optimization of protein tyrosine phosphatase 1B inhibitors: from the active site to the second phosphotyrosine binding site.
Wilson DP; Wan ZK; Xu WX; Kirincich SJ; Follows BC; Joseph-McCarthy D; Foreman K; Moretto A; Wu J; Zhu M; Binnun E; Zhang YL; Tam M; Erbe DV; Tobin J; Xu X; Leung L; Shilling A; Tam SY; Mansour TS; Lee J
J Med Chem; 2007 Sep; 50(19):4681-98. PubMed ID: 17705360
[TBL] [Abstract][Full Text] [Related]
5. Isoxazole carboxylic acids as protein tyrosine phosphatase 1B (PTP1B) inhibitors.
Zhao H; Liu G; Xin Z; Serby MD; Pei Z; Szczepankiewicz BG; Hajduk PJ; Abad-Zapatero C; Hutchins CW; Lubben TH; Ballaron SJ; Haasch DL; Kaszubska W; Rondinone CM; Trevillyan JM; Jirousek MR
Bioorg Med Chem Lett; 2004 Nov; 14(22):5543-6. PubMed ID: 15482920
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a potent, selective protein tyrosine phosphatase 1B inhibitor using a linked-fragment strategy.
Szczepankiewicz BG; Liu G; Hajduk PJ; Abad-Zapatero C; Pei Z; Xin Z; Lubben TH; Trevillyan JM; Stashko MA; Ballaron SJ; Liang H; Huang F; Hutchins CW; Fesik SW; Jirousek MR
J Am Chem Soc; 2003 Apr; 125(14):4087-96. PubMed ID: 12670229
[TBL] [Abstract][Full Text] [Related]
7. The structural basis for the selectivity of benzotriazole inhibitors of PTP1B.
Scapin G; Patel SB; Becker JW; Wang Q; Desponts C; Waddleton D; Skorey K; Cromlish W; Bayly C; Therien M; Gauthier JY; Li CS; Lau CK; Ramachandran C; Kennedy BP; Asante-Appiah E
Biochemistry; 2003 Oct; 42(39):11451-9. PubMed ID: 14516196
[TBL] [Abstract][Full Text] [Related]
8. Potent, selective inhibitors of protein tyrosine phosphatase 1B.
Xin Z; Oost TK; Abad-Zapatero C; Hajduk PJ; Pei Z; Szczepankiewicz BG; Hutchins CW; Ballaron SJ; Stashko MA; Lubben T; Trevillyan JM; Jirousek MR; Liu G
Bioorg Med Chem Lett; 2003 Jun; 13(11):1887-90. PubMed ID: 12749891
[TBL] [Abstract][Full Text] [Related]
9. Structure-based design and discovery of protein tyrosine phosphatase inhibitors incorporating novel isothiazolidinone heterocyclic phosphotyrosine mimetics.
Combs AP; Yue EW; Bower M; Ala PJ; Wayland B; Douty B; Takvorian A; Polam P; Wasserman Z; Zhu W; Crawley ML; Pruitt J; Sparks R; Glass B; Modi D; McLaughlin E; Bostrom L; Li M; Galya L; Blom K; Hillman M; Gonneville L; Reid BG; Wei M; Becker-Pasha M; Klabe R; Huber R; Li Y; Hollis G; Burn TC; Wynn R; Liu P; Metcalf B
J Med Chem; 2005 Oct; 48(21):6544-8. PubMed ID: 16220970
[TBL] [Abstract][Full Text] [Related]
10. Structure-based design of protein tyrosine phosphatase-1B inhibitors.
Black E; Breed J; Breeze AL; Embrey K; Garcia R; Gero TW; Godfrey L; Kenny PW; Morley AD; Minshull CA; Pannifer AD; Read J; Rees A; Russell DJ; Toader D; Tucker J
Bioorg Med Chem Lett; 2005 May; 15(10):2503-7. PubMed ID: 15863305
[TBL] [Abstract][Full Text] [Related]
11. Potent benzimidazole sulfonamide protein tyrosine phosphatase 1B inhibitors containing the heterocyclic (S)-isothiazolidinone phosphotyrosine mimetic.
Combs AP; Zhu W; Crawley ML; Glass B; Polam P; Sparks RB; Modi D; Takvorian A; McLaughlin E; Yue EW; Wasserman Z; Bower M; Wei M; Rupar M; Ala PJ; Reid BM; Ellis D; Gonneville L; Emm T; Taylor N; Yeleswaram S; Li Y; Wynn R; Burn TC; Hollis G; Liu PC; Metcalf B
J Med Chem; 2006 Jun; 49(13):3774-89. PubMed ID: 16789735
[TBL] [Abstract][Full Text] [Related]
12. Formylchromone derivatives as irreversible and selective inhibitors of human protein tyrosine phosphatase 1B. Kinetic and modeling studies.
Shim YS; Kim KC; Lee KA; Shrestha S; Lee KH; Kim CK; Cho H
Bioorg Med Chem; 2005 Feb; 13(4):1325-32. PubMed ID: 15670940
[TBL] [Abstract][Full Text] [Related]
13. Structure-based optimization of benzoic acids as inhibitors of protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase.
Maccari R; Ottanà R; Ciurleo R; Paoli P; Manao G; Camici G; Laggner C; Langer T
ChemMedChem; 2009 Jun; 4(6):957-62. PubMed ID: 19288492
[TBL] [Abstract][Full Text] [Related]
14. In silico structure-based design of a potent and selective small peptide inhibitor of protein tyrosine phosphatase 1B, a novel therapeutic target for obesity and type 2 diabetes mellitus: a computer modeling approach.
Rao GS; Ramachandran MV; Bajaj JS
J Biomol Struct Dyn; 2006 Feb; 23(4):377-84. PubMed ID: 16363874
[TBL] [Abstract][Full Text] [Related]
15. Investigations of linker structure on the potency of a series of bidentate protein tyrosine phosphatase inhibitors.
Xie J; Seto CT
Bioorg Med Chem; 2005 Apr; 13(8):2981-91. PubMed ID: 15781408
[TBL] [Abstract][Full Text] [Related]
16. The phosphatase domains of LAR, CD45, and PTP1B: structural correlations with peptide-based inhibitors.
Glover NR; Tracey AS
Biochem Cell Biol; 2000; 78(1):39-50. PubMed ID: 10735562
[TBL] [Abstract][Full Text] [Related]
17. Monocyclic thiophenes as protein tyrosine phosphatase 1B inhibitors: capturing interactions with Asp48.
Wan ZK; Lee J; Xu W; Erbe DV; Joseph-McCarthy D; Follows BC; Zhang YL
Bioorg Med Chem Lett; 2006 Sep; 16(18):4941-5. PubMed ID: 16806920
[TBL] [Abstract][Full Text] [Related]
18. Molecular dynamics simulations of interaction between protein-tyrosine phosphatase 1B and a bidentate inhibitor.
Liu GX; Tan JZ; Niu CY; Shen JH; Luo XM; Shen X; Chen KX; Jiang HL
Acta Pharmacol Sin; 2006 Jan; 27(1):100-10. PubMed ID: 16364216
[TBL] [Abstract][Full Text] [Related]
19. PTP1B as a drug target: recent developments in PTP1B inhibitor discovery.
Zhang S; Zhang ZY
Drug Discov Today; 2007 May; 12(9-10):373-81. PubMed ID: 17467573
[TBL] [Abstract][Full Text] [Related]
20. High-resolution structure of the Yersinia pestis protein tyrosine phosphatase YopH in complex with a phosphotyrosyl mimetic-containing hexapeptide.
Phan J; Lee K; Cherry S; Tropea JE; Burke TR; Waugh DS
Biochemistry; 2003 Nov; 42(45):13113-21. PubMed ID: 14609321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
